RNA-based pharmacotherapy for tumors: From bench to clinic and back - 14/03/20
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
pages | 15 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | RNA therapy mainly includes ASO, RNAi and mRNA therapy. |
• | A variety of mechanisms of RNA therapy work on target RNAs expression to cure diseases. |
• | RNA therapy destroys tumor cells by inhibiting proliferation and metastasis, and inducing apoptosis. |
• | Pharmacokinetics, pharmacodynamics, and drug production limit the development of RNA therapy to a large extent. |
Abstract |
RNA therapy is a treatment that regulates cell proteins and cures diseases by affecting the metabolism of mRNAs in cells, which has cut a figure in the studies on various incurable illnesses like hereditary diseases, tumors, etc. In this review, we introduced the discovery and development of RNA therapy and discussed its classification, mechanisms, advantages, and challenges. Moreover, we highlighted how RNA therapy works in killing tumor cells as well as what progresses it has made in related researches. And the development of RNA anti-tumor drugs and the clinical trial process were also included.
Le texte complet de cet article est disponible en PDF.Keywords : RNA therapy, RNA drugs, Cancer immunotherapy, Clinical trials
Plan
Vol 125
Article 109997- mai 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?